Ligand validation:6NIN

6PE: 1,2-DIHEXANOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE

6PE is a Ligand Of Interest in 6NIN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6NIN_6PE_E_1004	16%	65%	0.319	0.888	0.55	0.78	-	1	0	0	100%	1
6NIN_6PE_A_1004	3%	69%	0.476	0.815	0.54	0.67	-	1	0	0	100%	1
6NIN_6PE_W_1004	1%	67%	0.598	0.783	0.55	0.7	-	-	0	0	100%	1
6NHH_6PE_A_1004	49%	59%	0.126	0.872	0.88	0.69	2	-	0	0	100%	1
7TCE_6PE_K_1004	2%	60%	0.537	0.79	0.77	0.76	1	1	0	0	100%	1
7R3V_6PE_A_502	52%	63%	0.169	0.953	0.5	0.89	-	1	4	0	85%	0.8519
6HAW_6PE_A_501	33%	28%	0.208	0.916	1.54	1.35	2	3	2	0	85%	0.8519
6ZFS_6PE_A_501	27%	30%	0.233	0.905	1.52	1.29	2	2	0	0	85%	0.8519
6XVF_6PE_A_502	26%	28%	0.235	0.905	1.53	1.35	2	3	2	0	85%	0.8519
6ZFU_6PE_A_502	21%	27%	0.284	0.925	1.54	1.4	2	3	2	0	85%	0.8519

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.